Employees with close patient contact begin receiving Pfizer vaccine; older ages prioritized
Historic, hopeful moment arrives as COVID-19 vaccinations begin on Medical Campus (Links to an external site)
Category: ICTS News
WashU Technologies with a Positive Impact: Fall 2020 LEAP Funded Teams (Links to an external site)
The Fall 2020 Skandalaris LEAP cycle has ended and a new set of translational research projects have been funded. LEAP is an asset development program and gap fund designed to provide intellectual and financial capital to WashU affiliate translational projects.
Reflections on 2020 from the Center for Community Health Partnership and Research (Links to an external site)
CCHPR shares highlights from 2020 in end of year newsletter. Read it here.
ICTS investigator and ICU physician Kenneth E. Remy, MD pleads for public to wear masks in video (Links to an external site)
Young people with disabilities focus of COVID-19 testing grant (Links to an external site)
Researchers at Washington University School of Medicine in St. Louis have received a two-year, $5 million grant to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County (SSD).
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm (Links to an external site)
Findings indicate anti-inflammatory drugs likely to benefit only a fraction of people with severe disease
Unprecedented challenge. Unprecedented collaboration. (Links to an external site)
A look at how Washington University came together in the spring and summer to respond to the COVID-19 outbreak — and to prepare for a fall semester that is anything but back to normal.
Fluvoxamine may prevent serious illness in COVID-19 patients (Links to an external site)
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen […]
Cornea appears to resist infection from novel coronavirus (Links to an external site)
New findings from researchers at Washington University School of Medicine in St. Louis suggest the eye’s cornea can resist infection from the novel coronavirus. Although the herpes simplex virus can infect the cornea and spread to other parts of the body in patients with compromised immune systems, and Zika virus has been found in tears […]
COVID-19 Vaccine Trials at SLU and WashU Recruit St. Louis Area Residents (Links to an external site)
Rachel Presti, MD, PHD is the director of Washington University’s Infectious Diseases Clinical Research Unit and principal investigator for WashU’s COVID-19 vaccine trials. Sharon Frey, MD, is clinical director for SLU’s Center for Vaccine Development and principal investigator for SLU’s vaccine trials. Presti and Frey are coordinating so the two institutions can lead different vaccine […]